We're buying more shares of this undervalued health stock to maximize future returns

We're taking advantage of weakness in shares to average down in our position and maximize the upside from the eventual IPOs of Solta Medical and Bausch + Lomb.

from US Top News and Analysis https://ift.tt/q03ZLpR
https://ift.tt/Dm0WTGZ